Zymeworks ZYME Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $41.16M-37.7% | $66.1M-58.0% | $157.56M-60.7% | $400.91M+98.6% | ||
| $61.22M-57.1% | $142.55M-29.6% | $202.49M+607% | $28.65M— | ||
| $248.77M-17.2% | $300.45M-27.2% | $412.93M-24.2% | $544.71M+89.0% | ||
| $15.5M-12.2% | $17.65M-11.1% | $19.85M-19.7% | $24.71M+8.5% | ||
| $12.02M0.0% | $12.02M0.0% | $12.02M0.0% | $12.02M0.0% | ||
| $1.35M-70.5% | $4.58M-40.2% | $7.66M-12.6% | $8.76M+128% | ||
| $41.79M-57.5% | $98.43M+20.1% | $81.93M— | —— | ||
| $346.53M-25.2% | $463.09M-20.3% | $580.88M-10.5% | $648.73M+66.7% | ||
| $36.35M+831% | $3.9M-37.2% | $6.21M-21.0% | $7.86M+52.0% | ||
| $2.42M-90.6% | $25.59M+592% | $3.7M+57.2% | $2.35M— | ||
| $42.32M-52.1% | $88.29M+58.3% | $55.76M-41.7% | $95.63M+33.1% | ||
| $78.03M-37.2% | $124.32M+7.1% | $116.07M-25.5% | $155.77M+11.2% | ||
| 900M-11.4% | 1B+1.8% | 997.2M+12.5% | 886.3M+19.6% | ||
| -$953.16M-14.8% | -$830.34M-22.6% | -$677.44M-21.2% | -$558.76M+18.2% | ||
| $268.5M-20.7% | $338.77M-27.1% | $464.81M-5.7% | $492.96M+97.9% | ||
| $346.53M-25.2% | $463.09M-20.3% | $580.88M-10.5% | $648.73M+66.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can Zymeworks cover its short-term obligations?
- Its current ratio is 10.82 — current assets exceed current liabilities.
- Where does Zymeworks's balance sheet data come from?
- Every line is extracted from Zymeworks's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.